LigaChem Biosciences Decides on Paid-in Capital Increase
리가켐바이오
141080
Signal Score
Historical Avg Return (5d)
+0.31%
Data Coverage
100%n=2386
Risk-adjusted indicator based on 2386 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Board Resolution Date: June 25, 2026
- • Conversion Price: 149,300 KRW per share
- • Conversion Price Calculation Basis (Highest of C and D): 149,220 KRW
- • 1-month Weighted Average Stock Price (A): 142,195.70 KRW
- • 1-week Weighted Average Stock Price (B): 141,508.81 KRW
- • Latest Day Weighted Average Stock Price (C): 149,220.00 KRW
AI Analysis Summary
LigaChem Biosciences Inc. announced a decision on a paid-in capital increase via convertible preferred shares, with the board resolution dated June 25, 2026. The conversion price is set at 149,300 KRW per share, based on a 3.46% premium over the calculated reference stock price. The preferred shares carry voting rights identical to common shares and include a call option for the issuer from 24 to 48 months post-issuance, allowing the company to repurchase up to 10% of the shares at a price reflecting a 1% annual compound interest. The specific number of shares and total funding amount are not yet disclosed, pending confirmation of third-party allocators. The shares will be subject to a one-year lock-up period and will not be listed until converted to common shares. The purpose of the capital increase and the specific allocators will be disclosed in a subsequent amendment.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.